Professor of Molecular Therapeutics Susan Marqusee was selected as one of the Class of 2025 Protein Society Fellows. This honor, awarded by the Protein Society, recognizes current or past members of the Society who have demonstrated excellent science and service to the Society and the protein science community.
Department News
Below are articles from various sources about members of MCB and their research.


Assistant Professor of Biochemistry, Biophysics and Structural Biology James Nuñez was appointed as one of six 2025 Vallee Scholars. This award, from The Vallee Foundation, is awarded to early-career researchers at a pivotal stage of their tenure-track careers.

Professor of Molecular Therapeutics James Olzmann is the recipient of the 2026 American Society for Biochemistry and Molecular Biology (ASBMB) Avanti Award in Lipids. This award recognizes outstanding research contributions in the area of lipids.

Congratulations to Priya Moorjani on her promotion to MCB Associate Professor of Genetics, Genomics, Evolution, and Development!

Bay Area Biotech Day 2025: Bridging Academia and Industry for Transformative Drug Discovery

MCB is pleased to welcome our newest graduate students to the department! Learn fun facts about their favorite model organisms, childhood career aspirations, and more.
Photo credit: Shoey Sindel Photography

Interested in becoming a UC Berkeley faculty member in MCB? We are now accepting applications for an Assistant Professor for the MCB Division of Molecular Therapeutics (MTx).

Interested in becoming a UC Berkeley faculty member in MCB? We are now accepting applications for an Assistant Professor for the MCB Division of Immunology and Molecular Medicine (IMM).

Assistant Professor (Affiliated) of Cell Biology, Development and Physiology Ana Arruda is one of 22 researchers to be named 2025 Pew Scholars in the Biomedical Sciences. This award from the Pew Charitable Trusts is given to early-career scientists to uncover fundamental insights about human health and disease.

Professor of Molecular Therapeutics James Olzmann was named one of the fourteen American Society for Cell Biology (ASCB) 2025 Fellows. This award honors exceptional contributions to cell biology and the Society.